We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle (ALB) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Read MoreHide Full Article
In the latest close session, Albemarle (ALB - Free Report) was down 2.84% at $95.39. The stock's change was less than the S&P 500's daily loss of 1.09%. Elsewhere, the Dow saw a downswing of 0.34%, while the tech-heavy Nasdaq depreciated by 2.15%.
Heading into today, shares of the specialty chemicals company had lost 14.66% over the past month, lagging the Basic Materials sector's loss of 4.63% and the S&P 500's gain of 2.44%.
Investors will be eagerly watching for the performance of Albemarle in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on November 4, 2026. The company is expected to report EPS of $2.44, up 1384.21% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $1.49 billion, up 14.15% from the year-ago period.
ALB's full-year Zacks Consensus Estimates are calling for earnings of $11.3 per share and revenue of $6.09 billion. These results would represent year-over-year changes of +1530.38% and +18.41%, respectively.
Investors might also notice recent changes to analyst estimates for Albemarle. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.83% lower. Albemarle presently features a Zacks Rank of #3 (Hold).
Looking at valuation, Albemarle is presently trading at a Forward P/E ratio of 8.69. This expresses a discount compared to the average Forward P/E of 15.28 of its industry.
Also, we should mention that ALB has a PEG ratio of 0.58. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Chemical - Diversified industry had an average PEG ratio of 1.2 as trading concluded yesterday.
The Chemical - Diversified industry is part of the Basic Materials sector. This group has a Zacks Industry Rank of 183, putting it in the bottom 26% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Albemarle (ALB) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the latest close session, Albemarle (ALB - Free Report) was down 2.84% at $95.39. The stock's change was less than the S&P 500's daily loss of 1.09%. Elsewhere, the Dow saw a downswing of 0.34%, while the tech-heavy Nasdaq depreciated by 2.15%.
Heading into today, shares of the specialty chemicals company had lost 14.66% over the past month, lagging the Basic Materials sector's loss of 4.63% and the S&P 500's gain of 2.44%.
Investors will be eagerly watching for the performance of Albemarle in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on November 4, 2026. The company is expected to report EPS of $2.44, up 1384.21% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $1.49 billion, up 14.15% from the year-ago period.
ALB's full-year Zacks Consensus Estimates are calling for earnings of $11.3 per share and revenue of $6.09 billion. These results would represent year-over-year changes of +1530.38% and +18.41%, respectively.
Investors might also notice recent changes to analyst estimates for Albemarle. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.83% lower. Albemarle presently features a Zacks Rank of #3 (Hold).
Looking at valuation, Albemarle is presently trading at a Forward P/E ratio of 8.69. This expresses a discount compared to the average Forward P/E of 15.28 of its industry.
Also, we should mention that ALB has a PEG ratio of 0.58. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Chemical - Diversified industry had an average PEG ratio of 1.2 as trading concluded yesterday.
The Chemical - Diversified industry is part of the Basic Materials sector. This group has a Zacks Industry Rank of 183, putting it in the bottom 26% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.